Humankind Benefit Financial Statements From 2010 to 2024
| HKND Etf | USD 33.83 0.18 0.53% |
Check Humankind Benefit financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Humankind Benefit's main balance sheet or income statement drivers, such as , as well as many indicators such as . Humankind financial statements analysis is a perfect complement when working with Humankind Benefit Valuation or Volatility modules.
Humankind |
Humankind Benefit ETF Beta Analysis
Humankind Benefit's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Humankind Benefit Beta | 0.84 |
Most of Humankind Benefit's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Humankind Benefit is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Humankind Benefit has a Beta of 0.84. This is much higher than that of the Humankind family and significantly higher than that of the Large Value category. The beta for all United States etfs is notably lower than that of the firm.
About Humankind Benefit Financial Statements
Humankind Benefit stakeholders use historical fundamental indicators, such as Humankind Benefit's revenue or net income, to determine how well the company is positioned to perform in the future. Although Humankind Benefit investors may analyze each financial statement separately, they are all interrelated. For example, changes in Humankind Benefit's assets and liabilities are reflected in the revenues and expenses on Humankind Benefit's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Humankind Benefit. Please read more on our technical analysis and fundamental analysis pages.
The index is primarily comprised of domestic equity securities and may not be comprised of greater than 5 percent of foreign securities . Humankind is traded on NYSEARCA Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Humankind Benefit is a strong investment it is important to analyze Humankind Benefit's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Humankind Benefit's future performance. For an informed investment choice regarding Humankind Etf, refer to the following important reports:Check out the analysis of Humankind Benefit Correlation against competitors. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
The market value of Humankind Benefit is measured differently than its book value, which is the value of Humankind that is recorded on the company's balance sheet. Investors also form their own opinion of Humankind Benefit's value that differs from its market value or its book value, called intrinsic value, which is Humankind Benefit's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Humankind Benefit's market value can be influenced by many factors that don't directly affect Humankind Benefit's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Humankind Benefit's value and its price as these two are different measures arrived at by different means. Investors typically determine if Humankind Benefit is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Humankind Benefit's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.